GlassScriptPhysician profile
Leonardo David Salazar
NPI 1871114249
$3,408.82
in general payments reported to CMS, 2019-2025
15 companies · $2,308 in 2025
The $2,308 reported for 2025 was more than what 75% of Allergy & Immunology (Internal Medicine) providers received nationally (typical 2025 total: $681).
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.32 · 2023: $560 · 2024: $525 · 2025: $2,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803 · Education: $1,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,802.98 |
| Education | $1,589.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jubilant Hollisterstier LLC | $1,589.52 | 2025 | |
| Genzyme Corporation | $614.99 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $268.54 | 2023-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $220.57 | 2023-2025 | Nucala |
| Amgen INC. | $145.90 | 2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $122.10 | 2025 | Neffy |
| Pfizer INC. | $100.00 | 2023 | |
| Adma Biomanufacturing LLC | $98.36 | 2024 | |
| Beigene USA, INC. | $92.81 | 2024 | Brukinsa |
| Csl Behring | $46.03 | 2025 | Hizentra, Andembry |
| Takeda Pharmaceuticals U.S.A., INC. | $34.10 | 2022-2024 | Eohilia |
| Biocryst US Sales Co., LLC | $23.27 | 2023 | Orladeyo |
| Grifols USA, LLC | $18.69 | 2024 | Xembify |
| Galderma Laboratories, L.P. | $18.06 | 2025 | Nemluvio |
| Pharming Healthcare, INC. | $15.88 | 2023 | Ruconest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.